The population in Jordan mounted from half a million in 1952 to 5.3 millions in 2004 and is composed of a variety of ethnic groups, the majority being Arabs. Couples nowadays tend to have fewer children, with the total fertility rate falling from 7.4 in 1976 to 3.7 in 2004. Consanguineous marriages are traditionally favored, with the preferred marriage partner being the offspring of the father’s brother. First-cousin marriages declined from 28.5% for marriages contracted between 1950 and 1979 to 19.5% for marriages contracted after 1980. In the overall population, carrier rates for β-thalassemia, α-thalassemia and sickle cell anemia are in the range of 2–4%, 3.2–12% of males have glucose-6-phosphate dehydrogenase deficiency, and the prevalences for familial Mediterranean fever and cystic fibrosis were estimated at around 0.04% each. A mandatory premarital screening program for β-thalassemia carriers commenced in June 2004. The high consanguinity rate and the large family size in Jordan have contributed to the description of a number of rare and new autosomal recessive conditions. Genetic services in Jordan are still scarce and do not cover all the country due to the major impediments of a paucity of resources and trained health professionals in the area of medical genetics. The demographic data suggest that the health system in Jordan is capable of introducing some basic community genetic services into the primary health care program through comprehensive and cost-effective programs.

1.
Department of Statistics (DOS), The Hashemite Kingdom of Jordan. 2004. http://www.dos.gov.jo.
3.
Alwan A: Health in Jordan: an outline of the current situation and main challenges facing health development in Jordan. Geneva, World Health Organization and Ministry of Health publication, December 2005.
4.
The Library of Congress: A country study: Jordan. http://countrystudies.us/jordan.
5.
Khoury SA, Massad D: Consanguineous marriage in Jordan. Am J Med Genet 1992;43:769–775.
6.
Hamamy H, Jamhawi L, Al-darawsheh J, Ajlouni K: Consanguineous marriages in Jordan: why is the rate changing with time? Clin Genet 2005;67:511–516.
7.
al-Salem M, Rawashdeh N: Consanguinity in north Jordan: prevalence and pattern. J Biosoc Sci 1993;25:553–556.
8.
Khoury SA, Massad DF: Consanguinity, fertility, reproductive wastage, infant mortality and congenital malformations in Jordan. Saudi Med J 2000;21:150–154.
9.
Alwan A, Modell B: Community control of genetic and congenital disorders. EMRO technical publication series 24. Geneva, WHO Regional Office for the Eastern Mediterranean Region, 1997.
10.
Babiker M, Bashir N, Sarsour N: Prevalence of thalassaemia in schoolchildren in north-eastern Badia, Jordan. East Mediterr Health J 1999;5:1165–1170.
11.
Sunna EI, Gharaibeh NS, Knapp DD, Bashir NA: Prevalence of hemoglobin S and beta-thalassemia in northern Jordan. J Obstet Gynaecol Res 1996;22:17–20.
12.
Bashir N, Barkawi M, Sharif L, Momani A, Gharaibeh N: Prevalence of hemoglobinopathies in North Jordan. Trop Geogr Med 1992;44:122–125.
13.
Bashir N, Barkawi M, Sharif L: Prevalence of haemoglobinopathies in school children in Jordan Valley. Ann Trop Paediatr 1991;11:373–376.
14.
Talafih K, Hunaiti AA, Gharaibeh N, Gharaibeh M, Jaradat S: The prevalence of hemoglobin S and glucose-6-phosphate dehydrogenase deficiency in Jordanian newborn. J Obstet Gynaecol Res 1996;22:417–420.
15.
Sadiq MF, Eigel A, Horst J: Spectrum of beta-thalassemia in Jordan: identification of two novel mutations. Am J Hematol 2001;68:16–22.
16.
Karadsheh NS, Moses L, Ismail SI, Devaney JM, Hoffman E: Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Jordan. Haematologica 2005;90:1693–1694.
17.
Rawashdeh M, Majeed HA: Familial Mediterranean fever in Arab children: the high prevalence and gene frequency. Eur J Pediatr 1996;155:540–544.
18.
Majeed HA, El-Khateeb M, El-Shanti H, Rabaiha ZA, Tayeh M, Najib D: The spectrum of familial Mediterranean fever gene mutations in Arabs: report of a large series. Semin Arthritis Rheum 2005;34:813–818.
19.
Medlej-Hashim M, Rawashdeh M, Chouery E, Mansour I, Delague V, Lefranc G, Naman R, Loiselet J, Megarbane A: Genetic screening of fourteen mutations in Jordanian familial Mediterranean fever patients. Hum Mutat 2000;15:84.
20.
Nazer HM: Early diagnosis of cystic fibrosis in Jordanian children. J Trop Pediatr 1992;3:113–115.
21.
Rawashdeh M, Manal H: Cystic fibrosis in Arabs: a prototype from Jordan. Ann Trop Paediatr 2000;20:283–286.
22.
Eid SS, Rihani G: Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians. Clin Lab Sci 2004;17:200–202.
23.
Awidi AS, Abu-Khalaf M, Herzallah U, Abu-Rajab A, Shannak MM, Abu-Obeid T, al-Taher I, Anshasi B: Hereditary thrombophilia among 217 consecutive patients with thromboembolic disease in Jordan. Am J Hematol 1993;44:95–100.
24.
Awidi AS: A study of von Willebrand’s disease in Jordan. Ann Hematol 1992;64:299–302.
25.
Awidi AS: Congenital hemorrhagic disorders in Jordan. Thromb Haemost 1984 29;51:331–333.
26.
Al-Qudah AA, Tarawneh M: Congenital muscular dystrophy in Jordanian children. J Child Neurol 1998;13:383–386.
27.
Qumsiyeh M, Dasouki M, Teebi A: Genetic disorders among Jordanians and Palestinians; in Teebi AS, Farag TI (eds): Genetic Disorders among Arab Populations. New York, Oxford University Press, 1997.
28.
Abujbara MA, Hamamy HA, Jarrah NS, Shegem NS, Ajlouni KM: Clinical and inheritance profiles of Kallmann syndrome in Jordan. Reprod Health 2004;1:5.
29.
Hamamy H, Masri A, Ajlouni K: Wrinkly skin syndrome. Clin Exp Dermatol 2005;30:590–592.
30.
Jbour AK, Mubaidin AF, Till M, El-Shanti H, Hadidi A, Ajlouni KM: Hypogonadotrophic hypogonadism, short stature, cerebellar ataxia, rod-cone retinal dystrophy, and hypersegmented neutrophils: a novel disorder or a new variant of Boucher-Neuhauser syndrome? J Med Genet 2003;40:e2.
31.
El-Shanti H, Ahmad M, Ajlouni K: Alopecia universalis congenita, XY gonadal dysgenesis and laryngomalacia: a novel malformation syndrome. Eur J Pediatr 2003;162:36–40.
32.
Hiyasat D, Dehyyat MA, Ajlouni S, Mubaidin AF, Till M, Hadidi A, El-Shanti H, Ajlouni KM: Cerebellar hypoplasia, hypergonadotrophic hypogonadism, retinitis pigmentosa, alopecia, microcephaly, psychomotor retardation, and short stature: ‘D-CHRAMPS syndrome’. Eur J Pediatr 2002;161:170–172.
33.
Ferguson PJ, Chen S, Tayeh MK, Ochoa L, Leal SM, Pelet A, Munnich A, Lyonnet S, Majeed HA, El-Shanti H: Homozygous mutations in LPIN2 are responsible for the syndrome of chronic recurrent multifocal osteomyelitis and congenital dyserythropoietic anaemia (Majeed syndrome). J Med Genet 2005;42:551–557.
34.
El-Shanti H, Lidral AC, Jarrah N, Druhan L, Ajlouni K: Homozygosity mapping identifies an additional locus for Wolfram syndrome on chromosome 4q. Am J Hum Genet 2000;66:1229–1236.
35.
Mustapha M, Chouery E, Torchard-Pagnez D, Nouaille S, Khrais A, Sayegh FN, Megarbane A, Loiselet J, Lathrop M, Petit C, Weil D: A novel locus for Usher syndrome type I, USH1G, maps to chromosome 17q24–25. Hum Genet 2002;110:348–350.
36.
Christodoulou K, Zamba E, Tsingis M, Mubaidin A, Horani K, Abu-Sheik S, El-Khateeb M, Kyriacou K, Kyriakides T, Al-Qudah AK, Middleton L: A novel form of distal hereditary motor neuronopathy maps to chromosome 9p21.1–p12. Ann Neurol 2000;48:877–884.
37.
Mustapha M, Chouery E, Chardenoux S, Naboulsi M, Paronnaud J, Lemainque A, Megarbane A, Loiselet J, Weil D, Lathrop M, Petit C: DFNB31, a recessive form of sensorineural hearing loss, maps to chromosome 9q32–34. Eur J Hum Genet 2002;10:210–212.
38.
Santos RL, El-Shanti H, Sikandar S, Lee K, Bhatti A, Yan K, Chahrour MH, McArthur N, Pham TL, Mahasneh AA, Ahmad W, Leal SM: Novel sequence variants in the TMIE gene in families with autosomal recessive nonsyndromic hearing impairment. J Mol Med 2005;31:1–6.
39.
El-Shanti H, Daoud A, Sadoon AA, Leal SM, Chen S, Lee K, Spiegel R: A distinct autosomal recessive ataxia maps to chromosome 12 in an inbred family from Jordan. Brain Dev 2006;28:353–357.
40.
Al-Alami JR, Tanner SM, Tayeh MK, de la Chapelle A, El-Shanti H: Homozygous AMN mutation in hereditary selective intestinal malabsorption of vitamin B12 in Jordan. Saudi Med J 2005;26:1061–1064.
41.
Hampshire DJ, Roberts E, Crow Y, Bond J, Mubaidin A, Wriekat AL, Al-Din A, Woods CG: Kufor-Rakeb syndrome, pallido-pyramidal degeneration with supranuclear upgaze paresis and dementia, maps to 1p36. J Med Genet 2001;38:680–682.
42.
Najim al-Din AS, al-Kurdi A, Dasouki M, Wriekat AL, al-Khateeb M, Mubaidin A, al-Hiari M: Autosomal recessive ataxia, slow eye movements and psychomotor retardation. J Neurol Sci 1994;124:61–66.
43.
Abu-Heija AT: Causes and factors affecting perinatal mortality at Princess Basma Teaching Hospital in North Jordan. Asia Oceania J Obstet Gynaecol 1994;20:415–418.
44.
Khoury SA, Mas’ad DF: Causes of infant mortality in Jordan. Saudi Med J 2002;23:432–435.
45.
Annual Statistical Reports. Ministry of Health, Jordan, 1998–2005.
46.
Al Omari F, Al-Omari IK: Cleft lip and palate in Jordan: birth prevalence rate. Cleft Palate Craniofac J 2004;41:609–612.
47.
al-Salem M, Rawashdeh N: Pattern of childhood blindness and partial sight among Jordanians in two generations. J Pediatr Ophthalmol Strabismus 1992;29:361–365.
48.
Hamed RM, Shomaf M: Congenital nephrotic syndrome: a clinico-pathologic study of thirty children. J Nephrol 2001;14:104–109.
49.
Kharabsheh S, Belbesi A, Qarqash W, Azizi F: Goiter prevalence and urinary iodine excretion in schoolchildren of Jordan. Int J Vitam Nutr Res 2004;74:301–304.
50.
Zaidan I: Neonatal thyroid screening: analysis of three years experience (abstract). Proceedings of The First Jordanian National Conference for Neonatal Screening, April 2005.
51.
al-Qudah AA: Screening for congenital hypothyroidism in cognitively delayed children. Ann Trop Paediatr 1998;18:285–288.
52.
Towards a comprehensive food and nutrition policy in Jordan. Food and nutrition policy project, WHO/Ministries of Health and Agriculture, fourth draft, 2005.
53.
Al-Hait S: Phenylketonuria in Jordan: present and future (abstract). Proceedings of The First Jordanian National Conference for Neonatal Screening, April 2005.
54.
Albar M: Ethical considerations in the prevention and management of genetic disorders with special emphasis on religious considerations. Saudi Med J 2002;23:627–632.
55.
Daar AS, al Khitamy AB: Bioethics for clinicians: 21. Islamic bioethics. CMAJ 2001;164:60–63.
56.
Albar M: Induced abortion from an Islamic perspective: is it criminal or just elective? J Fam Community Med 2001;8:25–35.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.